192 related articles for article (PubMed ID: 21451818)
1. Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase.
Aguilar-Moncayo M; García-Moreno MI; Trapero A; Egido-Gabás M; Llebaria A; Fernández JM; Mellet CO
Org Biomol Chem; 2011 May; 9(10):3698-713. PubMed ID: 21451818
[TBL] [Abstract][Full Text] [Related]
2. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
3. Bicyclic isoureas derived from 1-deoxynojirimycin are potent inhibitors of β-glucocerebrosidase.
Sevšek A; Čelan M; Erjavec B; Quarles van Ufford L; Sastre Toraño J; Moret EE; Pieters RJ; Martin NI
Org Biomol Chem; 2016 Oct; 14(37):8670-3. PubMed ID: 27604065
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analogues.
Brumshtein B; Aguilar-Moncayo M; Benito JM; García Fernandez JM; Silman I; Shaaltiel Y; Aviezer D; Sussman JL; Futerman AH; Ortiz Mellet C
Org Biomol Chem; 2011 Jun; 9(11):4160-7. PubMed ID: 21483943
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
Diot JD; Garcia Moreno I; Twigg G; Ortiz Mellet C; Haupt K; Butters TD; Kovensky J; Gouin SG
J Org Chem; 2011 Oct; 76(19):7757-68. PubMed ID: 21830816
[TBL] [Abstract][Full Text] [Related]
6. Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.
Mena-Barragán T; García-Moreno MI; Sevšek A; Okazaki T; Nanba E; Higaki K; Martin NI; Pieters RJ; Fernández JMG; Mellet CO
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673163
[TBL] [Abstract][Full Text] [Related]
7. A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies.
Luan Z; Higaki K; Aguilar-Moncayo M; Li L; Ninomiya H; Nanba E; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2010 Nov; 11(17):2453-64. PubMed ID: 21064079
[TBL] [Abstract][Full Text] [Related]
8. Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
Trapero A; Alfonso I; Butters TD; Llebaria A
J Am Chem Soc; 2011 Apr; 133(14):5474-84. PubMed ID: 21413704
[TBL] [Abstract][Full Text] [Related]
9. N-Guanidino Derivatives of 1,5-Dideoxy-1,5-imino-d-xylitol are Potent, Selective, and Stable Inhibitors of β-Glucocerebrosidase.
Sevšek A; Šrot L; Rihter J; Čelan M; van Ufford LQ; Moret EE; Martin NI; Pieters RJ
ChemMedChem; 2017 Apr; 12(7):483-486. PubMed ID: 28328014
[TBL] [Abstract][Full Text] [Related]
10. Efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc) and sp(2)-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme.
de la Fuente A; Rísquez-Cuadro R; Verdaguer X; García Fernández JM; Nanba E; Higaki K; Ortiz Mellet C; Riera A
Eur J Med Chem; 2016 Oct; 121():926-938. PubMed ID: 26564401
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts.
Mena-Barragán T; García-Moreno MI; Nanba E; Higaki K; Concia AL; Clapés P; García Fernández JM; Ortiz Mellet C
Eur J Med Chem; 2016 Oct; 121():880-891. PubMed ID: 26361824
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of D-gluco-pyranocyclopropyl amines as potential glucosidase inhibitors.
Risseeuw MD; van den Berg RJ; Donker-Koopman WE; van der Marel GA; Aerts JM; Overhand M; Overkleeft HS
Bioorg Med Chem Lett; 2009 Dec; 19(23):6600-3. PubMed ID: 19853441
[TBL] [Abstract][Full Text] [Related]
13. 6-Amino-6-deoxy-5,6-di-N-(N'-octyliminomethylidene)nojirimycin: synthesis, biological evaluation, and crystal structure in complex with acid beta-glucosidase.
Brumshtein B; Aguilar-Moncayo M; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Silman I; Shaaltiel Y; Aviezer D; Sussman JL; Futerman AH
Chembiochem; 2009 Jun; 10(9):1480-5. PubMed ID: 19437524
[No Abstract] [Full Text] [Related]
14. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent-tagged sp2-iminosugars with potent β-glucosidase inhibitory activity.
Aguilar-Moncayo M; García-Moreno MI; Stütz AE; García Fernández JM; Wrodnigg TM; Ortiz Mellet C
Bioorg Med Chem; 2010 Nov; 18(21):7439-45. PubMed ID: 20889348
[TBL] [Abstract][Full Text] [Related]
16. N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
Désiré J; Mondon M; Fontelle N; Nakagawa S; Hirokami Y; Adachi I; Iwaki R; Fleet GW; Alonzi DS; Twigg G; Butters TD; Bertrand J; Cendret V; Becq F; Norez C; Marrot J; Kato A; Blériot Y
Org Biomol Chem; 2014 Nov; 12(44):8977-96. PubMed ID: 25277226
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective synthesis of 2-acetamido-1,2-dideoxynojirimycin (DNJNAc) and ureido-DNJNAc derivatives as new hexosaminidase inhibitors.
de la Fuente A; Mena-Barragán T; Farrar-Tobar RA; Verdaguer X; García Fernández JM; Ortiz Mellet C; Riera A
Org Biomol Chem; 2015 Jun; 13(23):6500-10. PubMed ID: 25975710
[TBL] [Abstract][Full Text] [Related]
18. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
[TBL] [Abstract][Full Text] [Related]
19. Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors.
Ghisaidoobe AT; van den Berg RJ; Butt SS; Strijland A; Donker-Koopman WE; Scheij S; van den Nieuwendijk AM; Koomen GJ; van Loevezijn A; Leemhuis M; Wennekes T; van der Stelt M; van der Marel GA; van Boeckel CA; Aerts JM; Overkleeft HS
J Med Chem; 2014 Nov; 57(21):9096-104. PubMed ID: 25250725
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
Yu L; Ikeda K; Kato A; Adachi I; Godin G; Compain P; Martin O; Asano N
Bioorg Med Chem; 2006 Dec; 14(23):7736-44. PubMed ID: 16919960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
